These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17584109)

  • 1. Growth factor therapy in atherosclerotic disease-friend or foe.
    Hoefer IE; Timmers L; Piek JJ
    Curr Pharm Des; 2007; 13(17):1803-10. PubMed ID: 17584109
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plaque angiogenesis and atherosclerosis.
    Moulton KS
    Curr Atheroscler Rep; 2001 May; 3(3):225-33. PubMed ID: 11286644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenesis as risk factor for plaque vulnerability.
    Di Stefano R; Felice F; Balbarini A
    Curr Pharm Des; 2009; 15(10):1095-106. PubMed ID: 19355951
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage.
    Virmani R; Kolodgie FD; Burke AP; Finn AV; Gold HK; Tulenko TN; Wrenn SP; Narula J
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2054-61. PubMed ID: 16037567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axitinib attenuates intraplaque angiogenesis, haemorrhages and plaque destabilization in mice.
    Van der Veken B; De Meyer GRY; Martinet W
    Vascul Pharmacol; 2018 Jan; 100():34-40. PubMed ID: 29079346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiogenesis in the atherosclerotic plaque.
    Camaré C; Pucelle M; Nègre-Salvayre A; Salvayre R
    Redox Biol; 2017 Aug; 12():18-34. PubMed ID: 28212521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiangiogenic therapy for normalization of atherosclerotic plaque vasculature: a potential strategy for plaque stabilization.
    Jain RK; Finn AV; Kolodgie FD; Gold HK; Virmani R
    Nat Clin Pract Cardiovasc Med; 2007 Sep; 4(9):491-502. PubMed ID: 17712362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological strategies to inhibit intra-plaque angiogenesis in atherosclerosis.
    Perrotta P; Emini Veseli B; Van der Veken B; Roth L; Martinet W; De Meyer GRY
    Vascul Pharmacol; 2019 Jan; 112():72-78. PubMed ID: 29933080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy?
    Kolodgie FD; Narula J; Yuan C; Burke AP; Finn AV; Virmani R
    J Am Coll Cardiol; 2007 May; 49(21):2093-101. PubMed ID: 17531658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory angiogenesis in atherogenesis--a double-edged sword.
    Ribatti D; Levi-Schaffer F; Kovanen PT
    Ann Med; 2008; 40(8):606-21. PubMed ID: 18608127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasa Vasorum Angiogenesis: Key Player in the Initiation and Progression of Atherosclerosis and Potential Target for the Treatment of Cardiovascular Disease.
    Sedding DG; Boyle EC; Demandt JAF; Sluimer JC; Dutzmann J; Haverich A; Bauersachs J
    Front Immunol; 2018; 9():706. PubMed ID: 29719532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arteriogenesis: basic mechanisms and therapeutic stimulation.
    Grundmann S; Piek JJ; Pasterkamp G; Hoefer IE
    Eur J Clin Invest; 2007 Oct; 37(10):755-66. PubMed ID: 17764463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of lipids and intraplaque hypoxia in the formation of neovascularization in atherosclerosis.
    Chistiakov DA; Melnichenko AA; Myasoedova VA; Grechko AV; Orekhov AN
    Ann Med; 2017 Dec; 49(8):661-677. PubMed ID: 28797175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neoplasms and angiogenesis].
    Lewy-Trenda I
    Pol Merkur Lekarski; 2002 Sep; 13(75):225-8. PubMed ID: 12474576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mechanisms and potential of the therapeutic stimulation of arteriogenesis].
    Schirmer SH; van Royen N; Laufs U; Böhm M
    Dtsch Med Wochenschr; 2009 Feb; 134(7):302-6. PubMed ID: 19197812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical interventions to influence arteriogenesis: new concepts to treat ischemic heart disease.
    Hoefer IE; Piek JJ; Pasterkamp G
    Curr Med Chem; 2006; 13(9):979-87. PubMed ID: 16611079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin promotes arteriogenesis and hemodynamic recovery in a rabbit hindlimb ischemia model.
    Katsanos K; Karnabatidis D; Diamantopoulos A; Kagadis GC; Ravazoula P; Nikiforidis GC; Siablis D; Tsopanoglou NE
    J Vasc Surg; 2009 Apr; 49(4):1000-12. PubMed ID: 19217750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis: new insights and therapeutic potential.
    Tomanek RJ; Schatteman GC
    Anat Rec; 2000 Jun; 261(3):126-35. PubMed ID: 10867630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arteriogenesis: a new strategy of therapeutic intervention in chronic arterial disorders. Cellular mechanism and experimental models].
    Erdo F; Buschmann IR
    Orv Hetil; 2007 Apr; 148(14):633-42. PubMed ID: 17403636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiogenesis Inhibitor, Endostar, Prevents Vasa Vasorum Neovascularization in a Swine Atherosclerosis Model.
    Xu X; Mao W; Chai Y; Dai J; Chen Q; Wang L; Zhuang Q; Pan Y; Chen M; Ni G; Huang Z
    J Atheroscler Thromb; 2015; 22(10):1100-12. PubMed ID: 26016418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.